rs281864923
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004211.5(SLC6A5):c.323del(p.Pro108LeufsTer27) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,607,440 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000012 ( 0 hom. )
Consequence
SLC6A5
NM_004211.5 frameshift
NM_004211.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0860
Genes affected
SLC6A5 (HGNC:11051): (solute carrier family 6 member 5) This gene encodes a sodium- and chloride-dependent glycine neurotransmitter transporter. This integral membrane glycoprotein is responsible for the clearance of extracellular glycine during glycine-mediated neurotransmission. This protein is found in glycinergic axons and maintains a high presynaptic pool of neurotransmitter at glycinergic synapses. Mutations in this gene cause hyperekplexia; a heterogenous neurological disorder characterized by exaggerated startle responses and neonatal apnea. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
?
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
?
Very rare variant in population databases, with high coverage;
PP5
?
Variant 11-20601443-GC-G is Pathogenic according to our data. Variant chr11-20601443-GC-G is described in ClinVar as [Pathogenic]. Clinvar id is 38371.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC6A5 | NM_004211.5 | c.323del | p.Pro108LeufsTer27 | frameshift_variant | 2/16 | ENST00000525748.6 | |
SLC6A5 | NM_001318369.2 | c.-241del | 5_prime_UTR_variant | 2/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC6A5 | ENST00000525748.6 | c.323del | p.Pro108LeufsTer27 | frameshift_variant | 2/16 | 1 | NM_004211.5 | P1 | |
SLC6A5 | ENST00000298923.11 | c.323del | p.Pro108LeufsTer27 | frameshift_variant, NMD_transcript_variant | 2/15 | 1 |
Frequencies
GnomAD3 genomes ? AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 34
GnomAD3 genomes
?
AF:
AC:
1
AN:
152196
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000173 AC: 4AN: 231172Hom.: 0 AF XY: 0.0000317 AC XY: 4AN XY: 126122
GnomAD3 exomes
AF:
AC:
4
AN:
231172
Hom.:
AF XY:
AC XY:
4
AN XY:
126122
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000117 AC: 17AN: 1455244Hom.: 0 Cov.: 58 AF XY: 0.0000152 AC XY: 11AN XY: 723446
GnomAD4 exome
AF:
AC:
17
AN:
1455244
Hom.:
Cov.:
58
AF XY:
AC XY:
11
AN XY:
723446
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74352
GnomAD4 genome
?
AF:
AC:
1
AN:
152196
Hom.:
Cov.:
34
AF XY:
AC XY:
0
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hyperekplexia 3 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 19, 2024 | This sequence change creates a premature translational stop signal (p.Pro108Leufs*27) in the SLC6A5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC6A5 are known to be pathogenic (PMID: 14622583, 16751771, 22700964). This variant is present in population databases (rs281864923, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with hyperekplexia (PMID: 22700964). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as DeltaC [319–323] (P108L + fs25). ClinVar contains an entry for this variant (Variation ID: 38371). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | curation | GeneReviews | Oct 04, 2012 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | May 11, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at